People: Tornier NV (TRNX.O)

TRNX.O on Nasdaq

26.11USD
3:39pm EDT
Change (% chg)

$0.10 (+0.38%)
Prev Close
$26.01
Open
$25.91
Day's High
$26.20
Day's Low
$25.74
Volume
60,924
Avg. Vol
187,642
52-wk High
$28.53
52-wk Low
$16.68

Search Stocks

McCormick, Shawn 

Mr. Shawn T. McCormick is Chief Financial Officer of Tornier NV since September 4, 2012. Prior to joining Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company acquired by C. R. Bard, Inc. in December 2011, from April 2011 to February 2012. From January 2009 to July.Mr. McCormick served as Senior Vice President and Chief Financial Officer of ev3 Inc., a global endovascular device company acquired by Covidien plc in July 2010. Prior to joining ev3, Mr. McCormick served as Vice President, Corporate Development at Medtronic, Inc., a global medical device company, where he was responsible for leading Medtronic’s worldwide business development activities. Mr. McCormick joined Medtronic in July 1992 and held various finance and leadership positions during his tenure. From July 2007 to May 2008, he served as Vice President, Corporate Technology and New Ventures of Medtronic. From July 2002 to July 2007, he was Vice President, Finance for Medtronic’s Spinal, Biologics and Navigation business. Prior to that, Mr. McCormick held various other positions with Medtronic. Mr. McCormick currently serves on the board of directors of Nevro, Inc. and Entellus Medical, Inc., all publicly held companies. Prior to joining Medtronic, he spent four years with the public accounting firm KPMG Peat Marwick. Mr. McCormick earned his Master of Business Administration from the University of Minnesota’s Carlson School of Management and his Bachelor of Science in Accounting from Arizona State University. He is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
194,908 -- 357,207 906,603

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Sean Carney

--

David Mowry

789,619

Kevin O'Boyle

--

Shawn McCormick

906,603

Kevin Klemz

573,573

Stephan Epinette

723,153
As Of  29 Dec 2012
Search Stocks